Implementing a Medication Switching Policy: Analysis of the Saskatchewan Biosimilars Initiative
Biologics are drugs that are uniquely created through advanced biotechnology. Biologics can be classified as either a reference biologic or a biosimilar. Reference biologics are innovator drugs whereas biosimilars are structurally similar, but not identical, to the reference biologic. Biologic drug...
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
McMaster University Library Press
2024-06-01
|
| Serie: | Health Reform Observer - Observatoire des Réformes de Santé |
| Soggetti: | |
| Accesso online: | https://mulpress.mcmaster.ca/hro-ors/article/view/5711 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|